Induction chemoradiotherapy versus induction chemotherapy for potentially resectable stage IIIA (N2) non-small cell lung cancer: a systematic review and meta-analysis.

Tong, Shaodong; Qin, Zhaohui; Wan, Minghui; Zhang, Longzhen; Cui, Yan; Yao, Yuanhu

Tong, Shaodong; Qin, Zhaohui; Wan, Minghui; Zhang, Longzhen; Cui, Yan; Yao, Yuanhu.

Afiliação

Tong S; Department of Radiation Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou 221000, China.
Qin Z; Jiangsu Key Laboratory of Biological Therapies for Tumors, Xuzhou Medical University, Xuzhou 221000, China.
Wan M; School of Public Health, Xuzhou Medical University, Xuzhou 221000, China.
Zhang L; Department of Radiation Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510260, China.
Cui Y; Department of Radiation Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou 221000, China.
Yao Y; Leibniz Institute on Aging-Fritz Lipmann Institute, Jena, Germany.

J Thorac Dis ; 10(4): 2428-2436, 2018 Apr.

Article em En | MEDLINE | ID: mdl-29850149

Palavras-chave

IIIA (N2); Non-small cell lung cancer (NSCLC); induction chemoradiotherapy; induction chemotherapy; meta-analysis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: J Thorac Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google